Architects of the EU’s landmark artificial intelligence act have urged Brussels to halt “dangerous” moves to water down the rules, which would spare big US tech groups such as OpenAI and Google from ...

Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis If approved, tolebrutinib would be the first and only brain-penetrant BTK inhibitor to ...